Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance

التفاصيل البيبلوغرافية
العنوان: Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance
المؤلفون: Jun Ma, Sze Huey Tan, Daniel Xing Cheng Yin, Nguyen Tuan Anh Tran, Gek San Tan, Gillianne Geet Yi Lai, Mei-Kim Ang, Ravindran Kanesvaran, Amit Jain, Tanujaa Rajasekaran, Eng-Huat Tan, Tony Kiat Hon Lim, Daniel Shao-Weng Tan, Darren Wan-Teck Lim, Quan Sing Ng, Wan Ling Tan
المصدر: Translational Lung Cancer Research. 12:742-753
بيانات النشر: AME Publishing Company, 2023.
سنة النشر: 2023
مصطلحات موضوعية: Oncology
تدمد: 2226-4477
2218-6751
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b8da70a772edaeabeb67786251739d58
https://doi.org/10.21037/tlcr-22-661
رقم الأكسشن: edsair.doi...........b8da70a772edaeabeb67786251739d58
قاعدة البيانات: OpenAIRE